

to improve their health
to deliver personalised care
to demonstrate impact for all stakeholders
Countries Live
Products
Released
Total App Downloads
As many as 1 in 4 patients are living with long term conditions.
The cost of caring for those patients is increasing.
Digital health products (DHPs) are the answer but an ever-changing deployment landscape is holding innovators back.
If you want to develop DHPs that:
then you need to build them on a single platform.
Avegen’s HealthMachine™ platform is your solution.
HealthMachine™ exists to achieve one thing – better outcomes for patients living with long term conditions.
HealthMachine™ deploys evidence-backed, user-validated, reusable modules to guarantee impact, while controlling costs.
HealthMachine™ stays ahead of the rapidly evolving security standards, privacy laws, mobile operating systems and the regulatory environment.
Whether you are a pharmaceutical company, a healthcare provider, or a research institute – HealthMachine™ delivers you best in class DHPs safely, quickly and affordably, in any indication area, that serve the patient need and meet your core business KPIs.
See how by exploring our latest case studies or book a demo today!
Engagement Lead
Patient
Pregnant mother
Regional Digital Stakeholder Engagement Lead
Problem Pulmonary arterial hypertension (PAH) is a rare, progressive, and life-threatening condition, for which there is no cure and therefore requires constant management by patients. Avegen was given the task to set-up a digital health solution that will support patient self-management and improve the patient-clinician connect. The goal of PAH management is to maintain low-risk […]
STOP (Successful Treatment Of Paranoia) is a patient-facing app that aims to reduce clinical symptoms of paranoia, in patients with mild to moderate paranoia. It is a self-administered 12-week programme using Cognitive Bias Modification for Interpretation therapy (CBM-I). Avegen in collaboration with King’s College London designed and set up STOP, the smartphone version of the therapy.
Klick is a digitally-enabled HIV care pathway conceptualised by Chelsea and Westminster Hospital Foundation Trust (CWFT), Avegen and a major pharmaceutical company. Klick was designed and built by Avegen to integrate with and enhance CWFT’s outpatient service model, whilst delivering a positive experience for patients.
The whole health ecosystem is building new competencies to deliver the best care for patients in this digital age.
The rate of innovation is only accelerating.
At Avegen, we are leveraging decades of experience in healthcare, empathy for the patient and belief in the power of data.
Our ambitious and visionary clients use HealthMachine™ to serve millions of patients around the world.
Together we are delivering the digital health platform of the future, today.
Get in touch to see how you can use HealthMachine™ to deliver a transformative digital health product to your patients in under 3 months.
Problem Pulmonary arterial hypertension (PAH) is a rare, progressive, and life-threatening condition, for which there is no cure and therefore requires constant management by patients. Avegen was given the task to set-up a digital health solution that will support patient self-management and improve the patient-clinician connect. The goal of PAH management is to maintain low-risk […]
STOP (Successful Treatment Of Paranoia) is a patient-facing app that aims to reduce clinical symptoms of paranoia, in patients with mild to moderate paranoia. It is a self-administered 12-week programme using Cognitive Bias Modification for Interpretation therapy (CBM-I). Avegen in collaboration with King’s College London designed and set up STOP, the smartphone version of the therapy.
Klick is a digitally-enabled HIV care pathway conceptualised by Chelsea and Westminster Hospital Foundation Trust (CWFT), Avegen and a major pharmaceutical company. Klick was designed and built by Avegen to integrate with and enhance CWFT’s outpatient service model, whilst delivering a positive experience for patients.